Welcome and General Session 4: The Evolving Landscape of Neuroendocrine Tumors

Jennifer A. Chan, MD, MPH—Chair, Dana-Farber Cancer Institute

Parag Parikh, MD—Chair, Henry Ford Cancer Institute

Shishir K. Maithel, MD, FACS
Winship Cancer Institute, Emory University
Welcome of the Day

Arvind Dasari, MD, MS
The University of Texas MD Anderson Cancer Center
Classification and Evaluation of NETs to Guide Management Strategies

James R. Howe, MD
University of Iowa Carver College of Medicine
Surgical Management of Neuroendocrine Tumors

Summary:
Optimal Surgical Approach to NETs
- Remove the primary
- Resect regional nodes
- Cholecystectomy
- Cytoreduce liver metastases
- Use Somatostatin analogues
- Use systemic therapy when other options not feasible or at progression

Erik Mittra, MD, PhD
Oregon Health and Science University
PRRT: Sequencing and Navigating the Treatment Armamentarium

Jennifer A. Chan, MD, MPH
Dana-Farber Cancer Institute
Current and Upcoming Clinical Trials